Acceptance and benefit of pruritus measurement in dermatological routine care

Acceptance and benefit of pruritus measurement in dermatological routine care - Pruritus measurement in dermatological routine care

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015305

Enrollment

250

Registered

2019-02-14

Start date

2018-10-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L29.8 L50.8 L40.0 L20.9 L28.1

Interventions

Group 1: Patients with psoriasis vulgaris, atopic dermatitis, chronic urticaria and chronic prurigo, who are treated within dermatologic routine care will answer the following four short, validated qu

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients -older than 18 years old -chronic pruritus (for more than 6 weeks) -intensity of pruritus higher than NRS 3 (24h) -one of the following four diagnoses: atopic dermatitis (L20.9), prurigo nodularis (L28.1), psoriasis vulgaris (L40.0) or chronic urticaria (L50.8).

Exclusion criteria

Exclusion criteria: -lack of understanding of the German language; -Patients who are not able to consent

Design outcomes

Primary

Measure	Time frame
-intensity of pruritus: Numeric Rating Scale NRS, Itch Controlled Days Questionnaire -quality of life: Dermatologic Life Quality Index DLQI, 5-PLQ -benefit to the Patient: Likert Scales -benefit to the physician: Likert Scales Measurement once per study visit	—

Secondary

Measure	Time frame
-clinical improvement during study horizon of 6-12 months	—

Countries

Germany

Contacts

Public ContactSabine Steinke

Klinik für Hautkrankheiten und Kompetenzzentrum chronischer Pruritus (KCP), Universitätsklinikum Münster

Sabine.Steinke@ukmuenster.de02518356510

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026